Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Antileishmanial activity and ultrastructural changes of related tetrahydrofuran dineolignans isolated from Saururus cernuus L. (Saururaceae)

Full text
Author(s):
Brito, Juliana R. [1] ; Passero, Luiz Felipe D. [2] ; Bezerra-Souza, Adriana [3] ; Laurenti, Marcia D. [3] ; Romoff, Paulete [4] ; Barbosa, Henrique [5] ; Ferreira, Edgard A. [4] ; Lago, Joao Henrique G. [5]
Total Authors: 8
Affiliation:
[1] Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Diadema - Brazil
[2] Univ Fed Sao Paulo, Inst Estudos Avancados Mar, Inst Biociencias, Sao Vicente - Brazil
[3] Univ Sao Paulo, Fac Med, Sao Paulo - Brazil
[4] Univ Presbiteriana Mackenzie, Escola Engn, Sao Paulo - Brazil
[5] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre - Brazil
Total Affiliations: 5
Document type: Journal article
Source: Journal of Pharmacy and Pharmacology; v. 71, n. 12, p. 1871-1878, DEC 2019.
Web of Science Citations: 0
Abstract

Objective This work describes the isolation of anti-Leishmania amazonensis metabolites from Saururus cernuus (Saururaceae). Additionally, ultrastructural changes in promastigotes were evidenced by electron microscopy. Methods The MeOH extract from the leaves of S. cernuus was subjected to bioactivity-guided fractionation. Anti-L. amazonensis activity of purified compounds was performed in vitro against promastigote and amastigote forms. Key findings Bioactivity-guided fractionation of the MeOH extract from the leaves of S. cernuus afforded two related tetrahydrofuran dineolignans: threo,threo-manassantin A (1) and threo,erythro-manassantin A (2). Compounds 1 and 2 displayed activity against promastigotes (EC50 of 35.4 +/- 7.7 and 17.6 +/- 4.2 mu m, respectively) and amastigotes (EC50 of 20.4 +/- 1.9 and 16.0 +/- 1.1 mu m, respectively), superior to that determined for the positive control miltefosine (EC50 of 28.7 +/- 3.5 mu m). Reduced cytotoxicity for host cells was observed for both compounds. Additionally, ultrastructural changes in promastigotes leading to an alteration of structural morphology were observed, as evidenced by electron microscopy. Furthermore, these compounds altered the morphology and physiology of the plasmatic membrane of L. amazonensis. Conclusions The obtained results indicated that dineolignans 1 and 2 could be considered as a scaffold for the design of novel and selective drug candidates for the treatment of leishmaniasis. (AU)

FAPESP's process: 18/07885-1 - Biomolecules from plant species of remnant areas of the Atlantic Forest and Cerrado to treat neglected tropical diseases - chemical and pharmacological aspects
Grantee:João Henrique Ghilardi Lago
Support Opportunities: BIOTA-FAPESP Program - Regular Research Grants
FAPESP's process: 16/00468-0 - Use of drug repurposing and natural product bioprospection to characterize compounds with in vitro and in vivo leishmanicidal action
Grantee:Luiz Felipe Domingues Passero
Support Opportunities: Regular Research Grants